Research Archive
June 2021
NTRA / Making Sense of the Signatera ADLT; Increasing Estimates, PT to $160 / Outperform
View research noteMay 2021
Life Science Tools and Diagnostics / Comparing Performance of Leading MRD Liquid Biopsy Tests as Early Data Emerges
View research noteApril 2021
Biopharma / Three DC Risks That Could Keep Biopharma Multiples Depressed All Year
View research noteMarch 2021
Life Science Tools and Diagnostics Volatility Creates Opportunities: Highlighting Winners Among the Crash Landing
View research noteFebruary 2021
Biopharma / 2021 MEDACorp IBD Physician Survey Shows Novel Orals Set to Expand Market
View research noteJanuary 2021
Biopharma / Biotech Financing in a COVID Year: Record Deal Flow, Record Capital Formation
View research noteDecember 2020
Biopharma / Vax Series #4: Shibboleths – Short-Lived Immunity, Vaccine Scarcity, Local Mfg.
View research noteNovember 2020
Biopharma / COVID – The Beginning of the End as the Pieces Fall into Place
View research noteOctober 2020
Life Science Tools and Diagnostics / Diving Deeper Into Multi-Cancer Liquid Biopsy Screening Tests
View research noteSeptember 2020
Biopharma / CD20xCD3 SmackDown: Let’s Get Ready to Rumble!!!
View research noteAugust 2020
It Ain’t Over Yet –COVID Vax Timeline Uncertain, Traditional Approach Preferred
View research noteJuly 2020
COVID Vaccine Series #1: Competitive Landscape, Timeline, and What to Expect
View research noteJune 2020
GILD / Upgrading to OP ($94 PT) on Remdesivir Sales, Arcus and Other Pipeline Options / Outperform
View research noteMay 2020
Biopharma/ Immuno-oncology: TIGIT & PVRIG Preview Heading into Catalyst-Rich Month
View research noteApril 2020